Japan approves AI software that uses MRI scans to identify depression, aiming to make diagnosis more objective.
Key Details
- 1AI algorithm detects signs of depression by analyzing MRI brain scans.
- 2Developed by the Advanced Telecommunications Research Institute International in Japan.
- 3Software provides visual evidence of brain activity alterations linked to depression.
- 4Regulatory approval granted in Japan; type not specified (likely a medical device approval).
- 5Conventional depression diagnoses typically rely on subjective patient reports and interviews.
Why It Matters
Objective tools for diagnosing depression could improve accuracy, standardization, and treatment selection in mental health care. The approval highlights expanding clinical roles for imaging AI, especially in neuropsychiatric applications.
Source
Health Imaging
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.